Share this article
Share this article
TOKYO, May 24, 2021 /PRNewswire/ Thirty years ago this month, the World Health Assembly (WHA) adopted a resolution to eliminate leprosy as a public health problem. Today, as the 74
th WHA gets under way, WHO Goodwill Ambassador for Leprosy Elimination Yohei Sasakawa is urging countries not to overlook leprosy amid the global coronavirus pandemic and aim for zero leprosy.
WHO Goodwill Ambassador for Leprosy Elimination Yohei Sasakawa (left) seen on one of his many visits to India, the country accounting for more than half the world’s annual new cases of leprosy.
The resolution adopted at the 44
Aiming for zero leprosy
0 Views
Aiming for zero leprosy. Image Source: IANS News
New Delhi, May 24 : Thirty years ago this month, the World Health Assembly (WHA) adopted a resolution to eliminate leprosy as a public health problem.
Today, as the 74th WHA gets under way, WHO Goodwill Ambassador for Leprosy Elimination Yohei Sasakawa is urging countries not to overlook leprosy amid the global coronavirus pandemic and aim for zero leprosy.
The resolution adopted at the 44th World Health Assembly in 1991 called for the elimination of leprosy as a public health problem at the global level by the year 2000. Elimination was defined as reaching a prevalence rate of the disease of less than 1 case per 10,000 population. This was achieved globally by the end of 2000 and almost all countries have since replicated that success at the national level.
Aiming for zero leprosy - INDIA New England News indianewengland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indianewengland.com Daily Mail and Mail on Sunday newspapers.
Novartis renews partnership with WHO to eradicate leprosy
Novartis renews partnership with WHO to eradicate leprosy
01 February 2021 | News The five-year extension of the partnership will see Novartis continue to donate multi-drug therapy (MDT) medicines to treat leprosy up to the end of 2025
Source credit: Shutterstock
A renewed partnership agreement signed by Novartis and the World Health Organization (WHO) will drive the global push towards making leprosy history. The five-year extension of the partnership – which was first signed in 2000 – will see Novartis continue to donate multi-drug therapy (MDT) medicines to treat leprosy up to the end of 2025. Leprosy can be cured and prevented. With a comprehensive approach, we can see the end of leprosy,” said Dr Lutz Hegemann, Chief Operating Officer, Global Health, Novartis. “By supplying this treatment free of charge to WHO over the last 20 years we have helped over seven million people be cured of leprosy. We l
Visit Novartis Global Health on Twitter and Linkedin.
Friday, January 29, 2021 - 1:15am
CONTENT: Press Release
BASEL, SWITZERLAND, January 29, 2021 /3BL Media/ A renewed partnership agreement signed by Novartis and the World Health Organization (WHO) will drive the global push towards making leprosy history. The five-year extension of the partnership – which was first signed in 2000 – will see Novartis continue to donate multidrug therapy (MDT) medicines to treat leprosy up to the end of 2025.
Widespread use of MDT has led to a 95% reduction in leprosy prevalence world-wide since its introduction the 1980s, though more than 200,000 cases are still seen every year.
1 Despite the huge impact of MDT, governments, donors, civil society and the private sector will need to collaborate on deploying additional tools if the world is to get to zero leprosy.